Open AccessA comparison between warfarin and apixaban: A patient's perspective
Author(s) -
Abdullah Althemery,
A. Alfaifi,
Abdulrahman Alturaiki,
Maha Al Ammari,
Khizra Sultana,
Leanne Lai
Publication year - 2020
Publication title -
annals of thoracic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.639
H-Index - 33
eISSN - 1817-1737
pISSN - 1998-3557
DOI - 10.4103/atm.atm_352_19
Subject(s) - apixaban , medicine , warfarin , confounding , propensity score matching , quality of life (healthcare) , rivaroxaban , atrial fibrillation , nursing
Novel oral anticoagulants (NOACs) were developed as alternatives to warfarin. However, the patients' preference regarding warfarin or the NOACs has not been established. Quality-of-life (QOL) surveys are a well-established method for determining the patients' preference for a treatment route.